Abstract: A multi-modal medicine delivery system in which some embodiments can be configured to control dispensation of medicine according to any of a plurality of delivery modes, such as by closed-loop delivery modes and open-loop delivery modes, and according to a secondary feedback loop to determine user-specific settings related to dosage delivery.
Abstract: An apparatus includes a catheter having a balloon including at least one first radiopaque marking. A guidewire guides the balloon to the treatment area, and includes at least one second radiopaque marking adapted for corresponding to the at least one first radiopaque marking of the balloon when positioned at the treatment area. Related aspects and methods are disclosed.
Type:
Grant
Filed:
September 24, 2018
Date of Patent:
April 20, 2021
Assignee:
CLEARSTREAM TECHNOLOGIES LIMITED
Inventors:
Corey E. Stapleton, Anne Hammond Cadillo
Abstract: An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate formed from a first material and a second material. At least one of the first and second materials includes a hemostatic agent. Kits, systems and methods are disclosed.
Type:
Grant
Filed:
May 1, 2017
Date of Patent:
April 20, 2021
Assignee:
MEDTRONIC, INC.
Inventors:
Satish Pulapura, Fatima Buevich, Jorie S. Soskin, Franklin R. Mansfield, Kai R. Worrell, Charlie Wood, Jorge Alberto Trevino Blanco, Narvel M. Brooks, III
Abstract: This invention relates to a multi-lumen flushable catheter device and a kit including this device. The multi-lumen catheter is made of a single lumen catheter in fluid connection with a multi-lumen catheter. The multi-lumen catheter includes a fluid lumen and a backflow connection lumen; wherein the fluid lumen and a backflow connection lumen are in fluid communication; a pressure control lumen made of a proximal port to receive a fluid such as air or a liquid and a distal balloon, the distal balloon is configured to block the single lumen catheter to prevent fluid flow into the single lumen catheter, wherein the pressure control lumen is not in fluid connection with the central lumen of the multi-lumen catheter. This device allows cleaning of in dwelling catheter in situ.
Abstract: A system for insufflating a vessel in a human or animal body, such as the rectum comprises a first pressure sensor located adjacent a leading end of an endoscope for monitoring pressure in the rectum. A second pressure sensor located on a carrier element which is urgeable through the endoscope into the colon monitors pressure therein. Insufflating air which may leak into the abdominal cavity is exhausted therefrom by a needle. A third pressure sensor monitors pressure in the abdominal cavity. A microcontroller controls the supply of insufflating air to the rectum for maintaining pressure in the rectum at a first predefined pressure, for preventing pressure in the colon exceeding a second predefined pressure, and for controlling a vacuum pump for drawing insufflating air from the abdominal cavity to prevent pressure therein exceeding a third predefined pressure.
Abstract: An automatic injection device has an insertion needle configured to be inserted into a patient and a drug container which contains a pharmaceutical product. The drug container includes a stopper. The automatic injection device also has a fluid path which fluidly connects the drug container to the insertion needle. The automatic injection device further has a drive system configured to cause parallel linear movement of the stopper to force the pharmaceutical product into the fluid path. The drive system has a driving element and a movable element. The automatic injection device additionally has electronics configured to provide a signal to the drive system to move the stopper and have means for sensing the stopper position. The movable element has an outer magnet at least partially surrounding the drug container and an inner magnet inside the drug container.
Abstract: The present invention provides devices to access the suprachoroidal space or sub-retinal space in an eye via a minimally invasive transconjunctival approach. The devices may also be used after a partial dissection, for example after dissection of the outer scleral layer of the eye, and using the device within the dissection to access the suprachoroidal space or the sub-retinal space.
Type:
Grant
Filed:
January 16, 2018
Date of Patent:
March 23, 2021
Assignee:
CLEARSIDE BIOMEDICAL, INC.
Inventors:
Amy Lee Hammack, Stanley R. Conston, Ronald Yamamoto
Abstract: The invention relates to an implantable access device for accessing the vascular system of a human or animal body, particularly subcutaneously implantable access port, comprising: at least one inlet opening, at least one outlet opening and at least one passageway between the at least one inlet opening and the at least one outlet opening, further comprising at least one valve assembly in the at least one passageway, which in a first, unactuated operating condition prevents a fluid flow through the at least one passageway and in a second, actuated operating condition permits a fluid flow through the at least one passageway, which is characterized in that the at least one valve assembly in the first, unactuated operating condition is longitudinally elongated and radially compressed in such a way to prevent a fluid flow through the at least one passageway and that the at least one valve assembly in the second, actuated operating condition is longitudinally compressed and radially elongated in such a way to permit
Type:
Grant
Filed:
March 29, 2018
Date of Patent:
March 9, 2021
Assignee:
PFM MEDICAL AG
Inventor:
Stanislas Marie Bertrand Achard de la Vente
Abstract: Mixing systems and methods include a mixing device comprising a primary tube having a proximal end, a distal end, an outer surface and an inner lumen and at least one secondary tube having a proximal end, a distal end, an outer surface and an inner lumen. The at least one secondary tube is substantially parallel to the primary tube. The distal end of the at least one secondary tube is fluidly connected to the primary tube at a junction located on the primary tube close to the distal end of the primary tube.
Type:
Grant
Filed:
July 30, 2018
Date of Patent:
March 9, 2021
Assignee:
Intravenous Solutions, Ltd.
Inventors:
Christopher Page, Stephen Probst, Thomas Corrado
Abstract: The present invention relates to a method of delivering drugs having e.g., anti-proliferative activity in the vascular, preferably, the cardiovascular, system locally or systematically using an at least partially drug-coated guidewire. The drug-coated guidewire, particularly an expansion member or portion thereof, is brought into contact with the target tissue or in circulation and the drugs are quickly released into the area surrounding the device in a short time after the contact step. Once the therapeutic drugs are released, they are quickly and effectively absorbed by the surrounding cells or circulation.
Abstract: In some examples, a catheter includes an elongated body comprising proximal and distal portions. The distal portion of the elongated body comprises an inner liner that includes a proximal liner section and a distal liner section that include different materials, and an outer jacket positioned over the inner liner. The distal liner section has a first hardness and the proximal liner section has a second hardness, where the first hardness is less than the second hardness.
Type:
Grant
Filed:
March 2, 2017
Date of Patent:
February 23, 2021
Assignee:
Covidien LP
Inventors:
George Stern, Edwin Bon, Edwin Wang, Ujwal Jalgaonkar, Peter Skujins
Abstract: An expandable sheath may include an inelastic compliant membrane having a lumen therethrough, and a discontinuous outer member bonded to the membrane. The membrane may include one or more folds formed therein. At least a portion of the outer member may extend continuously around a circumference of the membrane in a first configuration. The outer member may be configured to separate to a second configuration when subjected to a radially outward force from within the membrane. The outer member may taper from a first diameter adjacent a proximal hub to a second smaller diameter at a distal end. A method of manufacturing an expandable sheath may include forming one or more folds in a compliant membrane, cutting a plurality of apertures through a wall of an outer covering; and laminating the outer covering onto the membrane, wherein the plurality of apertures is disposed over the one or more folds.
Type:
Grant
Filed:
January 20, 2016
Date of Patent:
February 16, 2021
Assignee:
Boston Scientific Scimed, Inc.
Inventors:
Mimi Trinh Fitterer, Takashi H. Ino, Randy S. Gamarra, Floriza Q. Escalona
Abstract: Various embodiments of the present disclosure include a consumable capsule containing an active ingredient in at least one compartment movably sealed by a stimuli responsive actuator, and an activation device configured to communicate with the consumable capsule. The activation device is configured to emit a wireless signal to activate the stimuli responsive actuator of the consumable capsule, and the consumable capsule is configured to release the active ingredient into an external environment based on the activation of the stimuli responsive actuator.
Abstract: A catheter insertion device includes a housing, a needle, a guide wire, and a catheter disposed coaxially over the needle. The needle has a proximal end in the housing and a distal end extending from a distal end of the housing in an insertion position. The guide wire has a distal portion disposed in a lumen of the needle in a withdrawn position. The guide wire may include a safety tip having a non-coiled configuration in the withdrawn position and a coiled configuration in an advanced position. The catheter insertion device may include a sliding member attached to the guide wire, wherein movement of the sliding member translates the guide wire from the withdrawn position to the advanced position.
Type:
Grant
Filed:
September 25, 2015
Date of Patent:
February 9, 2021
Assignee:
Vascular Pathways, Inc.
Inventors:
Jessica A. Warring, Amir Belson, Winfield S. Fisher
Abstract: The present invention relates to electroporation (EP) devices that are able to generate an electroporation causing electrical field at the mucosal layer, and preferably in a tolerable manner. Further, it includes the generation of a protective immune response, cellular and/or humoral, using the oral EP device along with a genetic construct that encodes an immunogenic sequence.
Type:
Grant
Filed:
November 12, 2018
Date of Patent:
February 2, 2021
Assignee:
Inovio Pharmaceuticals, Inc.
Inventors:
Stephen V. Kemmerrer, Kate Broderick, Jay McCoy
Abstract: A balloon catheter comprises an elongated, tubular shaft extending in a longitudinal direction, said shaft having a proximal end and a distal end. An inflatable balloon is supported along the distal end of the shaft, the balloon when inflated including a generally cylindrical barrel section forming a working surface, and generally conical end sections that do not form a part of the working surface. The balloon further includes at least one radiopaque identifier for indicating the relative position of the working surface, said identifier being provided on at least one of the conical end sections of the balloon so as to define the extent of the working surface. Related aspects are also disclosed.
Type:
Grant
Filed:
August 31, 2018
Date of Patent:
January 26, 2021
Assignee:
CLEARSTREAM TECHNOLOGIES LIMITED
Inventors:
Angela Susan Crall, Scott Lee Randall, Robert Righi, Sean Wall
Abstract: A drug delivery device comprising a case adapted to hold a medicament container, a plunger disposed within the case and slidable from a proximal position into a distal position for delivering a medicament from the medicament container, an audible indicator that is arranged within a case pocket lateral to the plunger and that is in operative connection with the plunger, the audible indicator comprises at least one indicator spring and at least one locking element. The indicator spring is biased by the locking element, and the indicator spring relaxes due to a release of the locking element by a movement of the plunger.
Abstract: A disposable injector with a piston actuation ram is mounted in a housing, is loaded by a spring energy accumulator and can be unlocked by a displaceable trigger device. The piston actuation ram can be supported by a tensioning rod mounted in the housing. The trigger device comprises a trigger ring displaceable relative to the housing. The tensioning rod can be supported directly or indirectly by a bearing surface of the trigger ring. The bearing surface encloses an angle of between ten degrees and forty five degrees with the longitudinal direction of the disposable injector. The point of the angle lies offset with respect to the trigger ring in the triggering direction of the disposable injector. A disposable injector with increased trigger reliability is developed.
Type:
Grant
Filed:
October 25, 2017
Date of Patent:
January 12, 2021
Assignee:
LTS LOHMANN THERAPIE-SYSTEME AG
Inventors:
Sara Forghani, Uwe Wortmann, Karsten Heuser, Heiko Spilgies
Abstract: Methods of inserting a tube through the nasopharynx of a patient are disclosed. The methods of inserting a tube through a nasopharynx of a patient includes the steps of inserting the tube through a naris of the patient; and when a distal end of the tube is proximate a rear surface of the nasopharynx, pulling on or holding in place a thread-like member attached to a tube portion of the distal end of the tube so as to alter an initial direction of the distal end of the tube and point the distal end of the tube towards a throat of the patient. Kits for inserting a tube through the nasopharynx of a patient are also disclosed. The kits include a tube sized so as to move through a nasopharynx of a patient; and a thread-like member that is attachable to a tube portion of a distal end of the tube and can be tensioned so as to alter an initial direction of the distal end of the tube and point the distal end of the tube towards a throat of the patient.